Back to User profile » Dr Ida Parwati
Papers published by Dr Ida Parwati:
Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article
Achdiat PA, Suwarsa O, Hidayat YM, Shafiee MN, Dwiyana RF, Hindritiani R, Sutedja E, Pudjiati SR, Hilmanto D, Dhamayanti M, Parwati I, Maharani RH, Sutedja EK, Avriyanti E, Yunitasari
ImmunoTargets and Therapy 2024, 13:123-150
Published Date: 5 March 2024
The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival [Corrigendum]
Kumboyono K, Chomsy IN, Iskandar A, Aryati A, Parwati I, Wihastuti TA
Infection and Drug Resistance 2023, 16:3943-3944
Published Date: 20 June 2023
Antibiotic Resistance in COVID-19 with Bacterial Infection: Laboratory-Based Surveillance Study at Single Tertiary Hospital in Indonesia
Subagdja MFM, Sugianli AK, Prodjosoewojo S, Hartantri Y, Parwati I
Infection and Drug Resistance 2022, 15:5849-5856
Published Date: 4 October 2022
The Magnitude of Anxiety and Depressive Symptoms Among Tuberculosis Patients in Community Health Centers Setting During the Peak of COVID-19 Pandemic
Sunjaya DK, Paskaria C, Pramayanti M, Herawati DMD, Parwati I
Journal of Multidisciplinary Healthcare 2022, 15:755-764
Published Date: 8 April 2022
The Potential Predictive Role of Tumour Necrosis Factor-α, Interleukin-1β, and Monocyte Chemoattractant Protein-1 for COVID-19 Patients Survival
Kumboyono K, Chomsy IN, Iskandar A, Aryati A, Parwati I, Wihastuti TA
Infection and Drug Resistance 2022, 15:821-829
Published Date: 4 March 2022